Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price hit a new 52-week low on Monday . The stock traded as low as GBX 50.50 ($0.64) and last traded at GBX 52 ($0.65), with a volume of 219985 shares trading hands. The stock had previously closed at GBX 53.92 ($0.68).
Tissue Regenix Group Stock Performance
The company has a debt-to-equity ratio of 31.16, a current ratio of 4.03 and a quick ratio of 2.36. The firm has a market cap of £42.37 million, a price-to-earnings ratio of -48.52 and a beta of 1.61. The company has a fifty day moving average price of GBX 57.84 and a two-hundred day moving average price of GBX 58.58.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
See Also
- Five stocks we like better than Tissue Regenix Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is a Death Cross in Stocks?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Which Wall Street Analysts are the Most Accurate?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
